» Articles » PMID: 38862943

Clinical Features and Recurrence Predictors of Histiocytic Necrotizing Lymphadenitis in Chinese Children

Overview
Publisher Biomed Central
Specialty Pediatrics
Date 2024 Jun 11
PMID 38862943
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To characterize the clinical features and to identify the predictors of recurrence of histiocytic necrotizing lymphadenitis (HNL) in Chinese children.

Study Design: This study retrospectively analyzed the clinical characteristics, laboratory and pathological findings, and recurrence status of children diagnosed with HNL at a single center in China from January 2018 to May 2023. Logistic regression analysis was employed to identify predictors of HNL recurrence.

Results: 181 Chinese children with histopathologically confirmed HNL were enrolled (121 males and 60 females). The mean age was 9.3 ± 2.9 years. The most prominent clinical features were fever (98.9%) and cervical lymphadenopathy (98.3%). Aseptic meningitis was the most frequent complication (38.5%), while hemophagocytic lymphohistiocytosis and autoimmune disease were rare (1.7% and 1.2%, respectively). Recurrence occurred in 12.7% of patients. Erythrocyte sedimentation rate (> 30 mm/h) was the significant predictors of HNL recurrence, with odds ratios of 6.107, respectively.

Conclusion: Our study demonstrates that fever and cervical lymphadenopathy are the most frequent clinical manifestations of HNL in Chinese children, which often coexist with aseptic meningitis. HNL patients with risk factors require follow-up for recurrence.

Citing Articles

Histiocytic necrotizing lymphadenitis with autoimmune encephalitis in a child: a case report.

Zhou Y, Shu S Transl Pediatr. 2024; 13(10):1892-1898.

PMID: 39524397 PMC: 11543126. DOI: 10.21037/tp-24-380.

References
1.
Selvanathan S, Suhumaran S, Sahu V, Chong C, Tan N, Thoon K . Kikuchi-Fujimoto disease in children. J Paediatr Child Health. 2019; 56(3):389-393. DOI: 10.1111/jpc.14628. View

2.
Jung H, Lee I, Yoon S . Risk Assessment of Recurrence and Autoimmune Disorders in Kikuchi Disease. Risk Manag Healthc Policy. 2020; 13:1687-1693. PMC: 7519817. DOI: 10.2147/RMHP.S271283. View

3.
Shukla B, Aguilera E, Salazar L, Wootton S, Kaewpoowat Q, Hasbun R . Aseptic meningitis in adults and children: Diagnostic and management challenges. J Clin Virol. 2017; 94:110-114. PMC: 5581214. DOI: 10.1016/j.jcv.2017.07.016. View

4.
Faheem B, Kumar V, Ashkar H, Komal F, Sultana Y . Recurrent Kikuchi-Fujimoto Disease Masquerading as Lymphoma Successfully Treated by Anakinra. Cureus. 2021; 12(11):e11655. PMC: 7769493. DOI: 10.7759/cureus.11655. View

5.
Zaccarelli F, de Vincentiis M, DErme G, Greco A, Natalucci F, Fusconi M . Kikuchi-Fujimoto Disease: A Distinct Pathological Entity but also an "Overlap" Autoimmune Syndrome: A Systematic Review. Curr Rheumatol Rev. 2022; 19(2):159-167. DOI: 10.2174/1573397118666220903123128. View